Art

J-GLOBAL ID：201602209398297133   Reference number：16A0025457

Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer

肺癌における治療的意志決定へのアンプリコンベースの次世代シークエンシングの臨床応用

Author (19)： TAKEDA M. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  SAKAI K. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  TERASHIMA M. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  KANEDA H. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  HAYASHI H. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  TANAKA K. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  OKAMOTO K. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  TAKAHAMA T. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  YOSHIDA T. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  IWASA T. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  SHIMIZU T. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  NONAGASE Y. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  KUDO K. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  TOMIDA S. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  MITSUDOMI T. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  SAIGO K. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  ITO A. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  NAKAGAWA K. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN) ,  NISHIO K. (Kinki Univ. Fac. of Medicine, Osaka-Sayama, JPN)
Material： Annals of Oncology  (Ann Oncol)
Volume： 26  Issue： 12  Page： 2477-2482  Publication year： Dec. 2015 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： driver mutation ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0025457&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (2)： Tumors(=neoplasms)of respiratory system  (GI04000G) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (21)：

• Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004; 350: 2129-2139.
• Paez JG, Janne PA, Lee JC et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304: 1497-1500.
• Pao W, Miller V, Zakowski M et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004; 101: 13306-13311.
• Soda M, Choi YL, Enomoto M et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-566.
• Bergethon K, Shaw AT, Ou SH et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 2012; 30: 863-870.

Terms in the title (7)： 肺癌 ,  治療 ,  意志決定 ,  アンプリコン ,  次世代シークエンシング ,  臨床 ,  応用